Du, Xiaofeng
Kong, Desheng
Guo, Ruiyun
Liu, Boxin
He, Jingjing
Zhang, Jinyu
Amponsah, Asiamah Ernest
Cui, Huixian
Funding for this research was provided by:
Innovative Research Group Project of the National Natural Science Foundation of China (81801278)
Article History
Received: 3 February 2023
Accepted: 5 February 2024
First Online: 5 March 2024
Declarations
:
: The human PBMC collections and animal studies protocol were approved by the Committee of Ethics on Experimentation of Hebei Medical University (Assurance No. 20190505). Informed consent was obtained from all participants involved in the study. Title of an ethical approved project: Efficacy and mechanism of human iPSC derived neural stem cells in the treatment of spinal cord injury. Date of approval May 5, 2019. The experiments were conducted in accordance with the ARRIVE guidelines (ExternalRef removed) for the care and use of animals.
: Not applicable.
: The authors declare that they have no competing interests.